Literature DB >> 3822831

Genetic organization of the c-sis transcription unit.

A M Van den Ouweland, J J Van Groningen, J A Schalken, H W Van Neck, H P Bloemers, W J Van de Ven.   

Abstract

The structure and genetic organization of the transcription unit of the c-sis proto-oncogene was determined. Comparative nucleotide sequence analysis of the exon sequences of feline and human c-sis revealed a very high degree of homology. The cap site as well as the poly(A)-addition site of the sis transcript of each species was identified and found in similar positions. An insert of 4 amino acids was found in the deduced translational product of feline c-sis and it was located at the amino-terminus of the region that constituted the platelet-derived growth factor domain. An insert of 149 bp present at the 5' end of exon 7 of human c-sis but absent in the simian sarcoma virus v-sis oncogene was also present in the feline c-sis proto-oncogene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3822831      PMCID: PMC340501          DOI: 10.1093/nar/15.3.959

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments.

Authors:  J Messing; J Vieira
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

2.  Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine.

Authors:  K Takeda; J Minowada; A Bloch
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

Review 3.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

4.  Structure of the promoter for chicken alpha 2 type I collagen gene.

Authors:  G Vogeli; H Ohkubo; M E Sobel; Y Yamada; I Pastan; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  Human-proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus.

Authors:  S F Josephs; C Guo; L Ratner; F Wong-Staal
Journal:  Science       Date:  1984-02-03       Impact factor: 47.728

7.  Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor.

Authors:  K C Robbins; H N Antoniades; S G Devare; M W Hunkapiller; S A Aaronson
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

8.  The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes.

Authors:  P Besmer; H W Snyder; J E Murphy; W D Hardy; A Parodi
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

Authors:  R F Doolittle; M W Hunkapiller; L E Hood; S G Devare; K C Robbins; S A Aaronson; H N Antoniades
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

10.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

Authors:  M D Waterfield; G T Scrace; N Whittle; P Stroobant; A Johnsson; A Wasteson; B Westermark; C H Heldin; J S Huang; T F Deuel
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

View more
  8 in total

1.  Characteristics of a multicopy gene family predominantly consisting of processed pseudogenes.

Authors:  A M Van den Ouweland; H L Van Duijnhoven; K A Deichmann; J J Van Groningen; L de Leij; W J Van de Ven
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

2.  Do exons code for structural or functional units in proteins?

Authors:  T W Traut
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Regulation of expression of the c-sis proto-oncogene.

Authors:  L Ratner
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

4.  Sequences of the 5' portion of the human c-sis gene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5' untranslated mRNA sequences.

Authors:  L Ratner; B Thielan; T Collins
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

5.  Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing.

Authors:  D T Bonthron; C C Morton; S H Orkin; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  A novel human c-sis mRNA species is transcribed from a promoter in c-sis intron 1 and contains the code for an alternative PDGF B-like protein.

Authors:  R P Dirks; C Onnekink; H J Jansen; A de Jong; H P Bloemers
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

7.  Evaluation of a Standardized Protocol for Plasma Rich in Growth Factors Obtention in Cats: A Prospective Study.

Authors:  Laura Miguel-Pastor; Katy Satué; Deborah Chicharro; Marta Torres-Torrillas; Ayla Del Romero; Pau Peláez; José M Carrillo; Belén Cuervo; Joaquín J Sopena; José J Cerón; Mónica Rubio
Journal:  Front Vet Sci       Date:  2022-04-14

8.  Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet-derived growth factor isoform BB from feline platelet concentrates.

Authors:  Raul F Silva; María E Alvarez; Diana L Ríos; Catalina López; Jorge U Carmona; Cleuza Mf Rezende
Journal:  BMC Vet Res       Date:  2012-11-06       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.